Huaneng International and others set up a new energy company in Nanjing. According to Tianyancha App, Huaneng (Nanjing Jiangning) New Energy Co., Ltd. was established on December 9, with the legal representative of Wang Changbin and the registered capital of 164 million RMB. Its business scope includes power generation business, power transmission business, power supply (distribution) business, construction project supervision, wind power generation technical service, energy storage technical service, solar power generation technical service, and investment activities with its own funds. The company is jointly owned by Huaneng International Power Jiangsu Energy Development Co., Ltd. and Sino-Singapore Green Investment Private Co., Ltd. under Huaneng International (600011).Japan Life Insurance: Acquisition of American Resolution Life.At the beginning of the three major indexes, the GEM index rose by 0.39%, and the concepts of quantum technology and chips led the gains.
China's one-year interest rate swap hit a four-year low, and China's one-year interest rate swap (IRS) fell sharply this week, falling below the 1.50% mark for the first time since 2020. The data shows that the one-year interest rate swap was still around 1.50% at the beginning of Wednesday, and once fell to 1.4825% in the previous session, setting a new low since May 2020.At the beginning of the three major indexes, the GEM index rose by 0.39%, and the concepts of quantum technology and chips led the gains.Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.
Robot concept stocks fell at the opening, Hanwang Technology fell, Hanwang Technology and Shandong Mining Machine fell, and Sanfeng Intelligent, Tuosida, Hanwei Technology, Shuanglin, Weichuang Electric, Fengli Intelligent and Wuzhou Xinchun fell more than 5%.Guojin Securities: In 25 years or the first year of commercial mass production of humanoid robots, Guojin Securities said that Huawei's overweight body intelligence has become a new direction, which is expected to bring deterministic AI technology to domestic robot manufacturers and help domestic OEMs accelerate their rise. In 25 years or the first year of commercial mass production of humanoid robots, the domestic and international industries have resonated, and the humanoid robot industry has ushered in a period of rapid development and has plate investment opportunities. It is suggested to focus on the screw, reducer, torque sensor and domestic robot.The turnover of Shanghai and Shenzhen stock markets exceeded 500 billion.